Cannabis Law Report

JUNE 12, 2021

Here we undertake an analysis of this policy issue based on a case study of the introduction of medicinal cannabis in Australia. Road safety risks associated with medicinal cannabis appear similar or lower than numerous other potentially impairing prescription medications.

Policy 51

Policy Safety Medicine Access 51

NORML

AUGUST 26, 2019

Now, in 2015 — like in many other states throughout the country — we saw some fresh faces in the marijuana policy conversation. And instead of having the government arbitrarily select [qualifying] conditions, it would probably be a better public policy approach to let doctors decide. They managed to hold on to that.

Marijuana 247

Marijuana Legalization Programs Oil 247

NORML

JANUARY 27, 2020

The bill will have a hearing in the House Public Safety & Homeland Security Committee where committee members accept public comment before voting to release the bill to the full House for consideration. This change would allow registered patients and registered caregivers to grow medical cannabis at home.

Access 210

Access Cultivation Patients Strains 210

FloridaMarijuana.net

JULY 8, 2018

The endocannabinoid system consists of cannabinoid receptors all over the body. Medical marijuana and cannabinoids can be used to treat a patient’s physical and psychological health, alleviating the debilitating symptoms of PTSD. Cannabis offers significant therapeutic benefits for a wide range of medical conditions.

Strains 190

Strains Indica Hybrid Research and Development 190

Canna Law Blog

FEBRUARY 21, 2020

Specifically, the FSA is giving the CBD industry until March 31, 2021 to submit valid novel food authorization applications to ensure these products meet specific safety standards. The EFSA guidance on cannabinoids strongly echoes the U.S. The EFSA guidance on cannabinoids strongly echoes the U.S.

Food 120

Food CBD Legalization Hemp 120

Cannabis Law Report

JANUARY 30, 2022

Green Light Law Group: OLCC Finalizes New Rules on Delta-8 THC and other Artificially Derived Cannabinoids. The Oregon Liquor Control Commission (OLCC) recently finalized new administrative rules on Delta-8 THC and other artificially derived cannabinoids as … Read More. Per the CDC, … Read More.

Law 98

Law Cannabinoids Policy Legislation 98

Cannabis Law Report

MAY 9, 2022

Director of Policy (Deputy Director, NS) #10901. The Policy Director will also oversee the development and implementation of the Office’s public health educational campaign as well as the monitoring, surveillance, and reporting on key metrics related to the impacts of cannabis legalization. Range From $112155 to $141538 Annually.

Policy 52

Policy Research and Development Safety Data 52

Cannabis Law Report

NOVEMBER 2, 2021

NORML is pleased to announce that its newly updated and revised publication, Clinical Applications for Cannabis & Cannabinoids: A Review of the Recent Scientific Literature, 2000 — 2021 , is now available for download on the Kindle app. Proceeds from the purchase of the new book directly fund NORML’s cannabis advocacy efforts.

Safety 52

Safety Patients Chronic Pain Advocacy 52

The Blunt Truth

AUGUST 22, 2022

Employers can maintain a reasonable drug-free workplace policy that: Requires post-accident or reasonable suspicion drug testing of all employees or random drug testing of safety-sensitive workers; Is necessary to comply with federal law or a federal contract or funding agreement, if applicable to the employer; or.

Safety 111

Safety Environment Policy Recreational 111

Cannabis Law Report

NOVEMBER 15, 2021

As we collectively analyze and respond to emerging issues in the cannabis industry, we will continue to be the preeminent voice in cannabis regulatory policy.”. Lab Testing and Product Safety. Cannabinoid Hemp. Impaired Driving and Traffic Safety. Social and Economic Equity. Medical Use and Research. Public Education.

Compliance 98

Compliance Compliance Programs Topical 98

Cannabis Law Report

JUNE 21, 2021

The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Sydney, NSW 2050, Australia. Here we undertake an analysis of this policy issue based on a case study of the introduction of medicinal cannabis in Australia. Road safety. Medicinal cannabis. Access to treatment. Drug driving.

Medicine 45

Medicine Safety Policy Treatment 45

Cannabis Law Report

JUNE 10, 2021

Marijuana policies in the United States have become more permissive, motivating research on demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use. The Traffic Safety Culture Index is an annual survey with national scope and multiple measures relevant to driving after marijuana use.

Policy 45

Policy Safety Marijuana Data 45

Cannabis Law Report

MAY 23, 2022

Hemp Roundtable sent a letter to FDA Commissioner Robert Califf requesting the immediate issue of an enforcement discretion policy for dietary supplements containing hemp-derived CBD and other cannabinoids. Today, the U.S. Read the letter here.

Policy 52

Policy Hemp CBD Safety 52

Cannabis Law Report

AUGUST 11, 2022

An Oregon legislative task force established pursuant to HB 3000 (2021) and SB 1564 (2022) is developing policy proposals for 2023 relating to intoxicating cannabinoid products, illegal cannabis production, and water rights issues. Cannabinoid Subcommittee. Emphasis added by GLLG.).

Cannabinoids 52

Cannabinoids Legislation Hemp Safety 52

Veriheal

MARCH 25, 2024

Selling hemp, CBD (cannabidiol), and THC (tetrahydrocannabinol) products on Amazon’s marketplace is prohibited, but that hasn’t stopped sellers from finding ways to circumvent this policy. They found that only around 30% of them contained any CBD at all, and roughly 60% did not have any cannabinoids in them altogether.

Hemp 96

Hemp CBD Seed-To-Sale Policy 96

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

JANUARY 20, 2022

The Oregon Liquor Control Commission (OLCC) recently finalized new administrative rules on Delta-8 THC and other artificially derived cannabinoids as directed by HB 3000 (2021). Delta-8 THC and other Artificially Derived Cannabinoids. Artificially Derived Cannabinoids Allowed in SOME Situations.

Cannabinoids 52

Cannabinoids THC Food Hemp 52

The Cannigma

DECEMBER 20, 2021

If federal policy ensuring medical cannabis patients rights is not in place, rest assured there will be patients who struggle and suffer unnecessarily to get access to medicine and appropriate guidance on that medicine. As political pendulums swing, so too can state law, which we continue to see all around the country.

Medicine 136

Medicine Patients Cannabis Access 136

Cannabis Law Report

MARCH 26, 2022

A new commission for the United Kingdom (UK), the Hodges Review of UK Public Policy and Regulatory Stewardship of the Legal Cannabis Industry, will analyze its current legal cannabis industry and make recommendations on how to best maximize its growth, consumer satisfaction, and competitive potential on a global scale.

Cannabinoids 52

Cannabinoids Research and Development Supply Chain Policy 52

Project CBD

NOVEMBER 11, 2023

So just on safety alone, it’s worth using it. Cannabinoid receptors are distributed throughout the body and brain, and I think that also accounts for some of the varied effects of cannabis and the possibility that it can treat many different conditions. Which cannabinoids do you standardize for?

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). 1 Simultaneously, the AAFP acknowledges preliminary evidence indicates marijuana and cannabinoids may have potential therapeutic benefits, while also recognizing subsequent negative public health and health outcomes associated with cannabis use.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

APRIL 21, 2022

Unfortunately, this appetite combined with a lack of access to regulated marijuana has perpetuated both a robust and unregulated illicit marijuana market, and an unregulated hemp industry where intoxicating hemp-derived cannabinoids like Delta-8 THC, Delta-9 THC, THC-O and HHC are freely sold directly to consumers. If the plant tests above 0.3%

Cannabinoids 52

Cannabinoids Hemp Sativa THC 52

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. The document also addresses study participant safety emphasizing how psychedelics’ psychoactive effects increase the potential for abuse.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Canna Law Blog

FEBRUARY 14, 2019

The European Food Safety Authority (“ EFSA ”), the European equivalent of the U.S. Food and Drug Administration (“FDA”), recently changed guidance on cannabinoids, declaring that all new food products infused with the plant or its derivatives should receive a pre-market approval under the European Union “novel food” regulation.

Food 98

Food Seed-To-Sale CBD Sativa 98

Veriheal

AUGUST 16, 2023

As within the broader scope of player health and safety, we want to ensure every treatment at our disposal clears the appropriate medical standard for wider use.” In 2020 the NFL changed its drug testing policy, which was a significant development. They aim to promote education on the therapeutic properties of CBD.

CBD 98

CBD Research and Development Treatment Policy 98

Cannabis Law Report

JULY 30, 2021

With hemp already federally legal, a primary policy issue is how marijuana and hemp—two varieties of the cannabis plant—would be distinguished under a federal regulatory regime. We strongly encourage participation in this important opportunity to shape federal cannabis policy. Distinction between Cannabis and Hemp Under the CAOA.

Hemp 105

Hemp Law Seed-To-Sale Food 105

Illinois News Joint

NOVEMBER 6, 2024

and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta- 9 tetrahydrocannabinol concentration of not more than 0.3 The 2018 Farm Bill defines hemp to mean, “the plant Cannabis sativa L. percent on a dry weight basis.”

Hemp 78

Hemp Agriculture THC DEA 78

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Greenspoon Marder Cannabis Law Group Blog

AUGUST 6, 2019

The National Football League (NFL) preseason is upon us, and though the players may have changed, the league’s strict cannabis policies have not. According to a report from NBC Sports , “the NFL is prepared to make major concessions regarding the substance-abuse policy, especially as it relates to marijuana.”

Policy 40

Policy Chronic Pain Collective Cannabis 40

The Cannigma

NOVEMBER 2, 2021

The bad news is, these PGRs may seriously alter the flavor of cannabis, and questions remain about the effectiveness and safety of PGR cannabis. While this increases total weight, it interferes with natural cannabinoid and terpene production. The good news is, they are frequently employed to help increase cannabis bud production.

Trichome 140

Trichome Environment Cultivation Research and Development 140

CannaMD

FEBRUARY 18, 2020

After going to the school district’s workers’ compensation doctor, Hickman was drug tested – which was when he tested positive for cannabinoids. Heidi Maier : We moved on the side of caution, we kept our students safe, and most importantly in this case, we followed board policy. LAWMAKERS FIGHT TO CHANGE POLICY.

Marijuana 65

Marijuana Medicine Policy Safety 65

Canna Law Blog

AUGUST 22, 2019

On the legal side, doTERRA takes a conservative approach: doTERRA advises its distributors to “remain cautious” against products that may not follow the Federal Food, Drug, and Cosmetics Act (the “FD&C Act”) that may put health and safety at risk.

Oil 102

Oil CBD Education Cannabinoids 102

Cannabis Law Report

AUGUST 23, 2021

Abernethy said, “We [FDA] remain focused on exploring potential pathways for CBD products to be lawfully marketed while also educating the public about these outstanding questions of CBD’s safety.”. He added that significant data is still needed to inform policy regarding use of consumer cannabis products.

Pets 105

Pets Hemp CBD Food 105

Cannabis Law Report

JANUARY 10, 2020

Schlag has a keen interest in national and international drug policies, related regulatory challenges and public communications. Chair of Clinical Pharmacology, University of Newcastle; Director of the NHMRC-funded Australia Centre for Cannabinoid Clinical and Research Excellence (ACRE). Deepak Anand. Source: [link].

Research and Development 59

Research and Development Supply Chain Pharmaceutical Medicine 59

Cannabis Law Report

OCTOBER 9, 2019

Beyond Pesticides , October 8, 2019) As medicinal and recreational marijuana continue to be legalized in a growing number of states, concerns about the safety of the burgeoning industry—how the substance is grown, harvested, processed, distributed, sold, and used—have emerged. Congress should intervene to protect public health and safety.

Environment 55

Environment Safety Medicine Policy 55

Cannabis Law Report

JUNE 17, 2022

The bill’s protections do not extend to employees whose “position is designated as safety sensitive.” In 2019, Mayor Bowser signed an order into law eliminating random drug testing for District employees in non-safety sensitive positions. status as a medical cannabis program patient,” or.

Safety 52

Safety Legislation Policy Cannabis 52

Cannabis Law Report

JUNE 10, 2021

that demonstrate the safety and anti-inflammatory, anti-aging, and antimicrobial properties of Willow CBG on human skin. CBG is the most promising cannabinoid for skincare applications and we believe it will become a must have upgrade to people’s daily routines. ” About Cellular Goods PLC. Cellular Goods is a U.K.-based

Research and Development 66

Research and Development Cannabinoids Pharmaceutical Policy 66